Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
    August 27, 2012 - Institute. www.rti.org The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment …  Preferences among treatment alternatives depend on the relative importance of features. …  Respondents state preferences for series of constructed, hypothetical treatment alternatives … A Treatment B PAIN STIFFNESS STOMACH PROBLEMS Occasional mild … Treatment preferences and medication adherence of people with type 2 diabetes using oral glucose-lowering
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … Among PCI-assigned patients, use of stents and adjunctive medical therapy (e.g., dual antiplatelet therapy … Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic … with diabetes was reported by 6 RCTs … Comparative effectiveness by adjunctive therapies Adjunctive therapies Weak - RCTs did not provide comparative
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. … Males Females Age >= 75 Age < 75 Off Label No Diabetes Diabetes / non-insulin dep Diabetes / insulin … Males Females Age >= 75 Age < 75 Off Label No Diabetes Diabetes / non-insulin dep Diabetes / insulin … Males Females Age >= 75 Age < 75 Off Label No Diabetes Diabetes / non-insulin dep Diabetes / insulin … Males Females Age >= 75 Age < 75 Off Label No Diabetes Diabetes / non-insulin dep Diabetes / insulin
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-disposition-comments_0.pdf
    March 03, 2025 - Report Title: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes … Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, … The numbers of adolescents with type II diabetes are increasing and certainly many of these disease … treatment/management due to the widespread prevalence of overweight, obesity, prediabetes and type … , pre-diabetes, and overweight/obesity.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
    April 01, 2016 - How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD … summarize, interventions included for one or more of the key questions (KQs) are: • Nonpharmacologic therapies … Key Question 5: How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
    April 20, 2022 - Rates of HDP are rising in the U.S.,2 likely due to increased prevalence of pre-existing HTN, obesity, diabetes … the hypothesized reasons for the disparities relate to differential incidence of risk factors (e.g., diabetes … for HTN or HDP administered postpartum o Antihypertensive medications (single or combination therapies … For KQ 3, RCTs that compare MgSO4 with placebo, no treatment, or non-MgSO4 treatments (which are not … Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
    January 01, 2011 - requiring the use of contrast media; subgroups of interest include patients with renal dysfunction or diabetes … (serum creatinine or creatinine clearance), mortality, rate of renal recovery, adverse effects of treatment … What is the comparative efficacy of different therapies in preventing contrast- induced nephropathy? … factor for CIN, chronic kidney disease, is rising, driven in part by the increasing prevalence of diabetes
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - benefits in many outcome domains,9 and newer medications are replacing the conventional antipsychotics as treatments … Second-Generation Antipsychotics (Monotherapy) Second-Generation antipsychotics (Combination Therapytreatment in the context of previous episodes, and treatment resistance. … age, sex, race, weight, height, body mass index, comorbidities, use of concurrent standard medical therapies … Phenothiazines/ad, to, tu, ct, po, ae [Administration & Dosage, Toxicity, Therapeutic Use, Contraindications
  9. effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - , but less applicable to selecting among nonopioid treatments. … also reviewed evidence that may help inform decisions regarding prioritization of nonopioid drug therapies … by clinicians and patients when selecting therapy. … Opioid Treatments for Chronic Pain: A Systematic Review. … Noninvasive Nonpharmacologic Treatments for Chronic Pain: An Update.
  10. effectivehealthcare.ahrq.gov/health-topics/diabetic-eye-problems
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
    January 01, 2013 - type 1 diabetes mellitus; 3. iron deficiency anemia (IDA); 4. osteoporosis? b. … asymptomatic, at-risk populations (affected family members, patients with type 1 diabetes); iii. … follow-up testing; iii. invasive procedures (biopsies); iv. cases diagnosed; v. patients complying with treatment … ; and vi. response to treatment. 5.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - "[Mesh] OR "Endometriosis/therapy"[Mesh] OR "Nutrition Therapy"[Mesh] OR "Weight Loss"[Mesh] OR "Exercise … use”[MeSH] OR “Aspartic Acid/therapeutic use”[MeSH] OR “Citrulline/therapeutic use”[MeSH] OR “Flavonoids … /therapeutic use”[MeSH] OR “Adrenal Cortex Hormones”[MeSH] OR “Ejaculatory Ducts/therapy”[MeSH] OR " … infertility, other female causes of infertility, or common comorbidities such as hypertension and diabetes … infertility, other female causes of infertility, or common comorbidities such as hypertension and diabetes
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
    January 01, 2007 - What constitutes an adequate diagnostic evaluation on which to base treatment of UI? 2. … How effective is pharmacologic treatment of UI? 3. … How effective is non-pharmacologic treatment of UI? 4. … Does this make a clinical difference in response to treatment? 8. … factors  Prostate disorders  Dementia  Psychiatric disorders, specifically depression  Diabetes
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - recently and will be used in place of existing treatments in some patients and as an addition to treatment … The drug was FDA approved for treatment of type 2 diabetes in 2010, and was FDA approved for treating … for type 2 diabetes. … Hypertension Therapeutic device $1,000,000,000 $500,000,000 Lomitapide (Juxtapid) for Treatment … of Diabetes Implant $256,000,000 $256,000,000 Fluocinolone Acetonide Implant (Iluvien) for Treatment
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatmentsTreatment, therapy, or intervention -HSCT Intermediate Outcomes • Recurrence-free survival • … Treatment, therapy, or intervention -HSCT Intermediate Outcomes Slowing of the progression of or … Treatment, therapy, or intervention -HSCT Intermediate Outcomes • Stable source of endogenous … selection to the past 15 years to ensure that we identified evidence that is comparable in terms of therapeutic
  16. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-gaps-for-mhealth-tools-in-diabetes
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
    August 18, 2011 - Although medical researchers have demonstrated many efficacious medical treatments to improve health … actual treatment outcomes. … Diabetes Care 2001 Jan;24(1):124-30. PMID: 11194217. 8. … Adherence to Long Term Therapies: Evidence for Action. … Adherence to combination antiretroviral therapies in HIV patients of low health literacy.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - This tool was based on a previously developed and tested decision aid for diabetes.11 The structure, … design, and themes of the diabetes cards were modified to fit the needs of patients with anxiety and … address recently approved treatments. … Furthermore, if these clinics have an established first line treatment such as group therapy; implementation … The diabetes mellitus medication choice decision aid: a randomized trial.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
    September 01, 2013 - for PCI (two studies), diabetes mellitus (two studies), and chronic kidney disease (one study). … All seven were based on randomized trials comparing clopidogrel-based treatment with alternative therapies … The treatment comparisons were between standard-dose clopidogrel-based therapy and high-dose clopidogrel … Given the availability of several therapeutic options for antiplatelet treatment (e.g., increasing … Patients receiving different antiplatelet therapies whose choice of treatment was not based on CYP2C19
  20. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
    October 12, 2015 - , with 34.6 percent of couples having both male and female diagnoses.15 Available Treatments: Treatment … Syndrome/therapy"[Mesh]! OR!"Endometriosis/therapy"[Mesh]!OR!"Nutrition!Therapy"[Mesh]!OR!"Weight! … “Arginine/therapeutic!use”[MeSH]!OR!“Aspartic! Acid/therapeutic!use”[MeSH]!OR! … “Citrulline/therapeutic!use”[MeSH]!OR! “Flavonoids/therapeutic!use”[MeSH]!OR!“Adrenal!Cortex! … Ducts/therapy”[MeSH]!OR!"Varicocele/surgery"[Mesh]!OR!“Laser!Therapy”[MeSH]!OR!

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: